BMY formally discontinued Interferon Lambda, according to @JMPawlotsky. This is worth noting only because of the debate on this board a couple of years ago with respect to the medical and commercial value of this program and whether BMY “stole” ZymoGenetics (#msg-54152162).
“The efficient-market hypothesis may be the foremost piece of B.S. ever promulgated in any area of human knowledge!”
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.